Holen Sie sich die Stockscreener-App
3.37
1.20%
0.04
Schlusskurs vom Vortag:
$3.33
Offen:
$3.36
24-Stunden-Volumen:
141.59K
Relative Volume:
0.39
Marktkapitalisierung:
$267.43M
Einnahmen:
$351.37M
Nettoeinkommen (Verlust:
$-174.01M
KGV:
-1.628
EPS:
-2.07
Netto-Cashflow:
$-126.94M
1W Leistung:
+0.30%
1M Leistung:
-4.26%
6M Leistung:
+11.96%
1J Leistung:
-6.91%
1-Tages-Spanne:
$3.285
$3.405
1-Wochen-Bereich:
$3.285
$3.47
52-Wochen-Spanne:
$2.455
$4.145
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
Firmenname
Atea Pharmaceuticals Inc
Sektor
Branche
Telefon
857-204-8109
Adresse
225 FRANKLIN STREET, BOSTON
Vergleichen Sie AVIR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
3.37 | 264.26M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-13 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2023-08-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-18 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-20 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-10-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-25 | Eingeleitet | Evercore ISI | Outperform |
| 2020-11-24 | Eingeleitet | JP Morgan | Overweight |
| 2020-11-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Atea Pharmaceuticals Inc Aktie (AVIR) Neueste Nachrichten
Short interest data insights for Atea Pharmaceuticals Inc.July 2025 Technicals & Verified Entry Point Signals - Newser
What momentum shifts mean for Atea Pharmaceuticals Inc.Recession Risk & AI Forecast Swing Trade Picks - Newser
What’s next for Atea Pharmaceuticals Inc. stock price2025 Pullback Review & AI Driven Stock Reports - Newser
Signal strength of Atea Pharmaceuticals Inc. stock in tech scannersM&A Rumor & Safe Entry Point Identification - Newser
Will Atea Pharmaceuticals Inc. benefit from macro trendsWeekly Market Outlook & High Accuracy Buy Signal Tips - Newser
Should you hold or exit Atea Pharmaceuticals Inc. nowJuly 2025 Short Interest & Risk Controlled Daily Plans - Newser
Does Atea Pharmaceuticals Inc. offer margin of safetyJuly 2025 Highlights & High Accuracy Investment Signals - خودرو بانک
American Century Companies Inc. Purchases 17,666 Shares of Atea Pharmaceuticals, Inc. $AVIR - Defense World
Will Atea Pharmaceuticals Inc. outperform its industry peersPortfolio Value Summary & Growth-Oriented Investment Plans - خودرو بانک
What are Atea Pharmaceuticals Inc.’s earnings expectationsJuly 2025 Sentiment & Verified Entry Point Detection - خودرو بانک
Does Atea Pharmaceuticals Inc. qualify in momentum factor screeningJuly 2025 Short Interest & Low Risk High Reward Ideas - Newser
Evaluating Atea Pharmaceuticals Inc. with trendline analysisWall Street Watch & Expert Curated Trade Setups - Newser
Will Atea Pharmaceuticals Inc. announce a stock split2025 Trading Volume Trends & Weekly Hot Stock Watchlists - خودرو بانک
Building trade automation scripts for Atea Pharmaceuticals Inc.Fed Meeting & Technical Confirmation Alerts - Newser
What Fibonacci levels say about Atea Pharmaceuticals Inc. reboundAnalyst Upgrade & Advanced Swing Trade Entry Plans - Newser
Atea Pharmaceuticals’ Earnings Call Highlights HCV Progress - MSN
Does Atea Pharmaceuticals Inc. have strong fundamentals2025 Fundamental Recap & Weekly Breakout Watchlists - خودرو بانک
What is the earnings history of Atea Pharmaceuticals Inc.July 2025 Chart Watch & High Conviction Buy Zone Picks - خودرو بانک
How institutional ownership impacts Atea Pharmaceuticals Inc. stockTrade Risk Report & Target Return Focused Stock Picks - Newser
Multi factor analysis applied to Atea Pharmaceuticals Inc.2025 Momentum Check & Fast Moving Stock Trade Plans - Newser
Predicting Atea Pharmaceuticals Inc. trend using moving averagesTrend Reversal & Daily Technical Forecast Reports - Newser
Will Atea Pharmaceuticals Inc. price bounce be sustainableJuly 2025 Action & Daily Profit Focused Stock Screening - Newser
Analyzing Atea Pharmaceuticals Inc. with risk reward ratio chartsCEO Change & Safe Capital Preservation Plans - Newser
How cyclical is Atea Pharmaceuticals Inc.’s revenue streamGold Moves & Weekly Breakout Watchlists - خودرو بانک
Atea Pharmaceuticals Inc. stock daily chart insightsWeekly Profit Report & Weekly Breakout Opportunity Watchlist - Newser
Is Atea Pharmaceuticals Inc. meeting your algorithmic filter criteriaStock Surge & Risk Adjusted Buy/Sell Alerts - Newser
Is Atea Pharmaceuticals Inc. trending in predictive chart modelsEntry Point & Technical Pattern Alert System - Newser
What dividend growth rate does Atea Pharmaceuticals Inc. offer2025 Top Gainers & Stock Portfolio Risk Control - خودرو بانک
What technical models suggest about Atea Pharmaceuticals Inc.’s comebackCEO Change & Daily Entry Point Alerts - Newser
Using data tools to time your Atea Pharmaceuticals Inc. exitWeekly Market Outlook & Free Real-Time Volume Trigger Notifications - Newser
Can volume confirm reversal in Atea Pharmaceuticals Inc.July 2025 Short Interest & AI Enhanced Trade Execution Alerts - Newser
Is it too late to sell Atea Pharmaceuticals Inc.Trade Ideas & Capital Efficient Trading Techniques - Newser
Nuveen LLC Buys Shares of 291,091 Atea Pharmaceuticals, Inc. $AVIR - Defense World
Volatility clustering patterns for Atea Pharmaceuticals Inc.2025 Market Outlook & Reliable Breakout Forecasts - Newser
Russell Investments Group Ltd. Purchases 54,398 Shares of Atea Pharmaceuticals, Inc. $AVIR - Defense World
How to monitor Atea Pharmaceuticals Inc. with trend dashboardsJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - Newser
What to do if you’re stuck in Atea Pharmaceuticals Inc.Weekly Trade Summary & Technical Pattern Based Signals - Newser
what’s next for atea pharmaceuticals inc. stock price2025 Price Targets & Precise Trade Entry Recommendations - Newser
Is Atea Pharmaceuticals Inc. likely to announce a buybackGlobal Markets & Stepwise Trade Signal Implementation - خودرو بانک
Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewswire
Will Atea Pharmaceuticals Inc. outperform tech stocksJuly 2025 Technicals & Entry Point Confirmation Alerts - خودرو بانک
Atea Pharmaceuticals: Redefining Antiviral Therapeutics Through Strategic Innovation - AInvest
Finanzdaten der Atea Pharmaceuticals Inc-Aktie (AVIR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):